Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1081]

New approach to prostate cancer treatment

New approach to prostate cancer treatment

Breast cancer discovery could help prevent recurrence

Breast cancer discovery could help prevent recurrence

ESMO 2025: Drug combo cuts risk of death in advanced prostate cancer by 40%

ESMO 2025: Drug combo cuts risk of death in advanced prostate cancer by 40%

ESMO 2025: Novel treatment combination improves progression-free survival in metastatic, oestrogen-receptor-positive HER-2-negative breast cancer

ESMO 2025: Novel treatment combination improves progression-free survival in metastatic, oestrogen-receptor...

Personalised breast cancer therapy: A new treatment approach for patients with limited tamoxifen efficacy

Personalised breast cancer therapy: A new treatment approach for patients with limited tamoxifen efficacy

NRG Oncology PREDICT-RT study completes patient accrual, tests individualised concurrent therapy and radiation for high-risk prostate cancer

NRG Oncology PREDICT-RT study completes patient accrual, tests individualised concurrent therapy and radiation for...

Misconceptions keep some cancer patient populations from benefitting from hormone therapy

Misconceptions keep some cancer patient populations from benefitting from hormone therapy

New guidance on the management of aromatase inhibitor-associated bone loss in women with hormone-sensitive breast cancer

New guidance on the management of aromatase inhibitor-associated bone loss in women with hormone-sensitive breast...

Lower dose of abiraterone acetate as effective for prostate cancer treatment

Lower dose of abiraterone acetate as effective for prostate cancer treatment

Researchers capture first signs of ovarian cancer risk

Researchers capture first signs of ovarian cancer risk

More from ecancer